NetworkNewsBreaks Archive - Page 2107 of 2147

FridayJan 20, 2017 12:22 pm

NetworkNewsBreaks – Advanced Medical Isotope Corp. (ADMD) Targets Cancer, $1B Market with Brachytherapy Devices

Advanced Medical Isotope (OTC: ADMD) (“AMI”) develops cutting-edge brachytherapy devices for therapeutic applications, such as the Y-90 RadioGel™ device. Brachytherapy is the use of radiation to destroy cancerous tumors by placing a radiation source inside or next to the treatment area. AMI is in a booming industry, with the estimated annual sales of brachytherapy products exceeding $1 billion, about half of which are attributed to the United States. In October, the company reported that the first family pet, a cat, was treated for cancer with the company's pet version of the Y-90 RadioGel™ device. The study outcome data will be…

ThursdayJan 19, 2017 12:29 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on January 19, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: DELT 84.99% – News: Posts unaudited Q4 2016 sales results SGLB 64.40% – News: Enters long-term commercial agreement for PrintRite3D® with major European OEM NFEC 21.46% – News: Announces business cooperation with Indian Flucon International Co. Ltd. VRAY 17.52% – News: First ViewRay MRIdian Linac purchased by German Research Foundation since CE mark approval LXRP 14.59% – News: Releases positive results from cannabinoid tablet development trial with NeutriSci BHTG 13.46% – News: Launches updated…

ThursdayJan 19, 2017 12:26 pm

NetworkNewsBreaks – Celsius Holdings, Inc. (CELH) Sees Strength in International Presence, Sales

Celsius Holdings (OTCQX: CELH) is science-based beverage company actively expanding its international presence. The company most recently launched its CELSIUS® fitness drink into supermarkets, convenience and specialty stores and fitness centers in Singapore. News of this expansion followed a record third-quarter performance, marked by sales of $6.7 million, up 82% YoY. While domestic revenue grew 53%, the company saw particular strength in international sales, which increased 147%. Celsius in November also partnered with the A.S. Watson Group (ASW) for distribution of CELSIUS in Hong Kong and Macau, providing a foothold in the growing Chinese energy drink category. To learn more…

ThursdayJan 19, 2017 11:56 am

NetworkNewsBreaks – CV Sciences, Inc. (CVSI) Mines the Benefits of Science and Nature to Build Cannabidiol-Based Portfolio

The strategic integration of science and nature is the cornerstone of operations at CV Sciences (OTCQB: CVSI). Its Pharmaceuticals Division, for example, is developing synthetically formulated cannabidiol (CBD)‐based medicine for which the company is pursuing FDA approval. CV Sciences has achieved promising preclinical results in the development of cannabinoid medicines for the treatment of a range of medical conditions. The company’s initial drug candidate (CVSI-007) is a chewing gum containing nicotine and synthetic CBD to support cessation of smokeless tobacco use and addiction. Focusing on enhancing the quality of life, CV Sciences’ Consumer Products Division delivers botanical-based CBD products such…

ThursdayJan 19, 2017 11:53 am

NetworkNewsBreaks – PURE Bioscience, Inc. (PURE): 2017 Poised to be ‘Breakout Year’

Demonstrating the growing acceptance for its antimicrobial products, PURE Bioscience (OTCQB: PURE) recently posted first-quarter revenues of $531,000, up 186% year-over-year. Core food safety revenues increased 902% year-over-year, an achievement the company attributes to the accelerating momentum of its focused food safety strategy. PURE is pursuing regulatory approval for use of PURE Control in poultry online reprocessing, and said it expects FDA and USDA approvals in the second quarter of 2017. In its earnings release, company CEO Hank Lambert forecasts calendar 2017 as PURE’s “breakout year.” To learn more visit www.purebio.com About PURE Bioscience, Inc. PURE Bioscience, Inc. is focused…

ThursdayJan 19, 2017 11:51 am

NetworkNewsBreaks – Sphere 3D (NASDAQ: ANY) Inks Deal to Acquire HVE and Unified ConneXions; Shares Higher

Shares of Sphere 3D (NASDAQ: ANY) are up 28% after the data management company said it will acquire HVE (Hybrid Virtualization Engine) ConneXions and its sister company, Unified ConneXions, Inc., which achieved combined virtualization revenue of more than $7 million for calendar year 2016. The acquired companies’ products, technologies and professional services will expand Sphere 3D’s virtualization practice and increase its ability to accelerate the delivery of hybrid cloud solutions. The acquisition is anticipated to close before January 31, 2017, and is expected to be accretive in the first quarter of 2017. “UCX has exceptional leadership teams, innovative technology, industry…

ThursdayJan 19, 2017 11:48 am

NetworkNewsBreaks – Rosetta Genomics Ltd. (NASDAQ: ROSG) Sets Stage for Value Creation in 2017

Rosetta Genomics (NASDAQ: ROSG) is an international company leveraging a growing IP portfolio to develop and commercialize microRNA-based and other molecular diagnostic programs in cancer and various other indications. In 2016, Rosetta was primarily focused on the commercial launch of its Reveal assay for the classification of indeterminate thyroid nodules, and it signed an exclusive distribution agreement with Rhenium Ltd. for the sales and marketing of Reveal in Israel. In a December earnings release, Rosetta Genomics said it expects FY2017 RosettaGX Reveal revenue to be between $4 million and $5 million. The company is also advancing a number of other…

WednesdayJan 18, 2017 2:23 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on January 18, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: VPRB 18.09% – News: Presenting at 2017 Big Industry Show in Los Angeles on January 19-20th NXTD 16.48% – News: Posts preliminary results for the year and quarter ended December 31, 2016 UNXL 11.90% – News: Announces preferred equity financing for $3M; Enters into MOU with GIS HPCQ 12.26% – News: Adds Myco BioBoost to product line ESEA 7.83%– News: Announces delivery of Newbuilding Ultramax Drybulk Carrier STLT 7.25% – News: Subsidiary Caretta Therapeutics…

WednesdayJan 18, 2017 2:19 pm

NetworkNewsBreaks – BiondVax Pharmaceuticals’ (NASDAQ: BVXV) Flu Vaccine Candidate Shows Potential to Cover Mutating Strains

One of the primary concerns of conventional vaccination is historically low efficacy. BiondVax (NASDAQ: BVXV), which earlier this month received an investment of $2.8 million to continue its development, is focused on creating a universal flu vaccine that would provide effective, multi-season protection. The company’s M-001 vaccine was recently featured in peer-reviewed scientific journal Vaccine, which reports that M-001 administered in the 2011 flu season significantly increased protective antibodies against the strain (A/Swiss) that caused the 2014/2015 influenza epidemic. Notably, the A/Swiss strain did not exist when M-001 was administered several years before. The results demonstrate M-001’s ability to provide…

WednesdayJan 18, 2017 1:25 pm

NetworkNewsBreaks – aTyr’s (NASDAQ: LIFE) Resolaris™ Obtains Fast Track Designation from FDA, Partial Clinical Hold Removed

Shares of aTyr Pharma (NASDAQ: LIFE) climbed more than 25% in mid-day trade following news that the company’s Resolaris™ candidate was granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of limb girdle muscular dystrophy 2B, making it the first known therapeutic candidate to receive the designation for this treatment. The FDA also removed its partial clinical hold on a dosing ceiling for Resolaris in clinical trials, providing dosing flexibility moving forward. "This Fast Track designation, which is granted to drug candidates addressing serious conditions and that demonstrate the potential to address unmet medical…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks